Strategic appointments support product pipeline growth

To facilitate its drive to scale-up manufacturing of infectious disease reagents, antibodies and assays since moving to new premises opened by parent company LGC Clinical Diagnostics, The Native Antigen Company announced the key appointments of Richard White, Business Development Manager and Pardeep Sharda, Senior Product Manager. The transition to the new facility based at the Oxford Technology Park, form part of its strategy to further expand its extensive product portfolio, with over 30 new products in the pipeline.

Richard, who will be responsible for growing the Company’s presence in the North American market, brings with him over 20 years’ diverse commercial experience in multiple functions including sales, marketing and diagnostics. His expertise includes developing and executing tactical business strategies to enhance efficiency and branding for diagnostics. As Senior Product Manager, Pardeep will focus on building and developing marketing strategies both for the Company’s existing product range and assisting in the design of innovative new products. He has extensive experience in driving marketing strategies, with his most recent roles including Senior Global Product Manager at QIAGEN, and Marketing Manager at Roche.

Ish Jalal, Commercial Director, The Native Antigen Company, said: “These appointments mark a major milestone for us as we continue to grow the Company both in terms of size and of our product offerings. Coupled with the news of our brand new, cutting-edge facilities opening in Oxford, the expansion of our senior team makes for a very exciting time for The Native Antigen Company.”

Richard White, commented: “I’m looking forward to working with the team at The Native Antigen Company, continuing on the growth trajectory that the Company has already seen over the past few years. With the Company’s recent move to new facilities, we have greatly increased our capacity, giving exciting opportunities for new business, as well as enabling us to continue to anticipate and support our existing customer’s needs.”

Pardeep Sharda added: “This is a fantastic time to be joining the team, as we enter the next stage of the Company’s development. With LGC’s backing, there is huge scope for further product development and expansion of our core capabilities, which I am looking forward to being a part of.”

The 36,000 square foot facility was officially opened in October by the creators of the Oxford AstraZeneca COVID-19 vaccine, Dame Sarah Gilbert DBE and Teresa Lambe OBE. As well as hosting the manufacturing facilities for The Native Antigen Company, it also houses an advanced workflow applications laboratory for LGC Biosearch Technologies.

More information online